H101 is an E1B/E3B-deleted adenovirus that restricts p53-mutated neoplasm replication, sparing p53 wild-type tissues.39 The decreased cancer-specific mortality for HCC patients treated with combined TACE and H101 therapy compared with TACE therapy alone may be explained by the following mechanism. Here, TP53 is linked to cancer.